Vaccine News and Research

Latest Vaccine News and Research

Immunotherapy accepted for coverage in MEDLINE®

Future Medicine Ltd announced today that its journal Immunotherapy (ISSN 1750-743X) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine, MEDLINE® (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

19 Sep 2010

Johnson & Johnson in talks to buy Crucell

Johnson & Johnson is in advanced negotiations to buy Dutch biotechnology company Crucell NV for €1.75 billion ($2.29 billion), the two companies said today. Giles Somers, senior healthcare analyst at Datamonitor comments:

19 Sep 2010

Anthem Blue Cross hosts Hmong Health Awareness Fair with local health and community agencies

Tomorrow, Anthem Blue Cross State Sponsored Business will team with local health and community agencies to host the Hmong Health Awareness Fair. Local health and community organizations will be on hand to provide local families free health screenings, vaccines and health information. The health fair will take place from 9:00 a.m. to 3: p.m. at the Asian Village Shopping Center located at 4903 E. Kings Canyon Road.

18 Sep 2010

Study finds mothers' education levels affect child mortality

A study published in the journal Lancet on Friday found that "a mother's education level has a huge, if indirect, effect on the health of her children," the Washington Post reports.

18 Sep 2010

CytoGenix initiates novel liner DNA technology testing on ferrets for vaccine development

CytoGenix, Inc. today announced that it has initiated the process of testing CytoGenix's novel liner DNA technology on ferrets, with the expectations of a positive result, furthering the development of the vaccine candidate.

18 Sep 2010

Walgreens pharmacists in California offer immunizations that protect against pertussis

With the state of California on pace for the worst epidemic of pertussis, or whooping cough, in nearly five decades, officials from the Centers for Disease Control and Prevention as well as the California Department of Public Health continue to strongly encourage vaccination to help increase immunity and stop the spread of the disease for all Californians.

18 Sep 2010

CMB initiates first human trial for plant-produced H1N1 influenza vaccine

Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today it has initiated the first human trial of plant-produced H1N1 influenza vaccine at the Walter Reed Army Institute of Research Clinical Trials Center (WRAIR-CTC).

18 Sep 2010

Emergent BioSolutions signs contract with HHS to develop rPA anthrax vaccine

Emergent BioSolutions Inc. announced today that it has signed a contract, valued at up to $186.6 million, with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the development of a recombinant protective antigen anthrax vaccine.

18 Sep 2010

BARDA awards contract to Emergent BioSolutions for anthrax vaccine development

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) awarded a $51 million contract to Emergent BioSolutions, Inc., of Rockville, Md., for the development of a new anthrax vaccine using the protective antigen (rPA) to stimulate a protective immune response that neutralizes the anthrax toxins.

18 Sep 2010

Biotechnology Institute announces classroom program to improve U.S. life science education quality

Biotechnology industry leaders announced today a major new program to improve the quality of U.S. life science education. The Biotechnology Institute's new "Scientists in the Classroom" initiative is the life science industry's response to President Obama's "Educate to Innovate" campaign to improve the performance of America's students in science, technology, engineering, and mathematics (STEM) education.

17 Sep 2010

Developing Countries Vaccine Manufacturers to strengthen alliance with GAVI

Developing Countries Vaccine Manufacturers Network (DCVMN), a voluntary public health driven alliance of state owned and private vaccine manufacturers from developing countries, now intends to strengthen its collaboration with Global Alliance for Vaccine Immunization (GAVI) to increase its bandwidth in immunization for the developing countries.

17 Sep 2010

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Johnson & Johnson and Crucell N.V. today announced that they are in advanced negotiations for a potential public offer by Johnson & Johnson or an affiliate for all outstanding ordinary shares of Crucell not already held by Johnson & Johnson and its affiliates.

17 Sep 2010

Generex presents Ii-Key hybrids product development at Gene based Vaccines conference

Generex Biotechnology Corporation today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. The presentations were made at the conference Gene based Vaccines: Optimizing Development and Delivery 2010 held September 13 and 14, 2010 in Vienna, Austria and at the Immunotherapeutics and Vaccine Summit held in Cambridge, MA from August 17-19, 2010.

17 Sep 2010

Scripps Research Institute receives grant to develop DNA sequencing technology

Scripps Research Institute Professor Reza Ghadiri, Ph.D., has been awarded a four-year, $5.1 million grant as part of a National Institutes of Health (NIH) initiative to spur the development of the next generation of DNA sequencing technologies, which could enable biomedical researchers and health care workers to routinely sequence a person's DNA.

17 Sep 2010

LigoCyte to enroll 98 subjects in first clinical trial for bivalent IM norovirus vaccine

LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company focused on the development of innovative vaccine products, announced today that it has initiated the first clinical trial for its bivalent intramuscular (IM) norovirus vaccine candidate, marking the fourth human clinical trial in the Company's norovirus virus-like particle (VLP) vaccine program.

17 Sep 2010

ImmunoCellular contracts with Averionto to execution ICT-107 cancer-vaccine Phase II study

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has contracted with the clinical research organization (CRO) Averion International Corp. to conduct its planned Phase II study of ICT-107, the Company's lead cancer-vaccine candidate for the treatment of glioblastoma multiforme (GBM).

17 Sep 2010

Scientists discover simple molecular test to block GOAT enzyme

Scientists at The Scripps Research Institute have designed a new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the appetite and play a role in diabetes.

17 Sep 2010

Researchers identify mechanism to reduce pathogenic effect of bacillus bacteria

A European-Asian collaboration of scientists, notably including CNRS, the Institut Pasteur in Paris, the Institut Pasteur Korea in Seoul (IP Korea/Equipe Avenir Inserm and the Université de Toulouse have identified ten virulence genes of the tubercle bacillus. The inactivation of these genes lessens the pathogenic effects of the bacillus.

16 Sep 2010

Wistar Institute scientists publish detailed report on structure, function of Cdc13 domain in protein

Scientists at The Wistar Institute have published the first detailed report on the structure and function of a crucial domain in the protein known as Cdc13, which sustains telomeres by clamping to DNA and recruiting replicating enzymes to the area.

16 Sep 2010

Advanced Life Sciences participates as exhibitor in 50th ICAAC

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today participated in the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy

16 Sep 2010

Vaccine News and Research

Latest Vaccine News and Research

Immunotherapy accepted for coverage in MEDLINE®

Johnson & Johnson in talks to buy Crucell

Anthem Blue Cross hosts Hmong Health Awareness Fair with local health and community agencies

Study finds mothers' education levels affect child mortality

CytoGenix initiates novel liner DNA technology testing on ferrets for vaccine development

Walgreens pharmacists in California offer immunizations that protect against pertussis

CMB initiates first human trial for plant-produced H1N1 influenza vaccine

Emergent BioSolutions signs contract with HHS to develop rPA anthrax vaccine

BARDA awards contract to Emergent BioSolutions for anthrax vaccine development

Biotechnology Institute announces classroom program to improve U.S. life science education quality

Developing Countries Vaccine Manufacturers to strengthen alliance with GAVI

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Generex presents Ii-Key hybrids product development at Gene based Vaccines conference

Scripps Research Institute receives grant to develop DNA sequencing technology

LigoCyte to enroll 98 subjects in first clinical trial for bivalent IM norovirus vaccine

ImmunoCellular contracts with Averionto to execution ICT-107 cancer-vaccine Phase II study

Scientists discover simple molecular test to block GOAT enzyme

Researchers identify mechanism to reduce pathogenic effect of bacillus bacteria

Wistar Institute scientists publish detailed report on structure, function of Cdc13 domain in protein

Advanced Life Sciences participates as exhibitor in 50th ICAAC

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in